Pacira BioSciences' Operating Income rose 10455.97% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.6 million, marking a year-over-year increase of 16402.24%. This contributed to the annual value of -$73.4 million for FY2024, which is 18368.52% down from last year.
As of Q3 2025, Pacira BioSciences' Operating Income stood at $6.4 million, which was up 10455.97% from $8.5 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Operating Income registered a high of $39.9 million during Q2 2023, and its lowest value of -$139.5 million during Q3 2024.
In the last 5 years, Pacira BioSciences' Operating Income had a median value of $17.7 million in 2023 and averaged $9.5 million.
Per our database at Business Quant, Pacira BioSciences' Operating Income skyrocketed by 58751.92% in 2021 and then plummeted by 88735.4% in 2024.
Quarter analysis of 5 years shows Pacira BioSciences' Operating Income stood at $4.2 million in 2021, then tumbled by 334.93% to -$9.9 million in 2022, then skyrocketed by 435.27% to $33.2 million in 2023, then dropped by 25.52% to $24.7 million in 2024, then crashed by 74.25% to $6.4 million in 2025.
Its last three reported values are $6.4 million in Q3 2025, $8.5 million for Q2 2025, and $2.0 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value